Aisling Capital portfolio
Aisling Capital (Venture capital) is known to hold 118 companies, 22 of them startups. 27 of them are hiring now, with 3,178 open roles. Its companies closed 3 venture rounds in 12 months, raising -. Most of them work in Prescription Drugs, Biologics & Biosimilars, Oncology Therapeutics.
Companies Aisling Capital has invested in
Open roles at Aisling Capital portfolio companies
Focus
Co-investors
Similar investors
their companies share markets and countries
Questions about Aisling Capital
How many companies has Aisling Capital invested in?
Aisling Capital is known to hold 118 companies: 22 startups, and 35 exits so far, read from its own portfolio page and the funding rounds that name it.
Is Aisling Capital investing now?
Aisling Capital has no round in the press in 12 months and no new company on its portfolio page in 90 days.
What does Aisling Capital invest in?
The markets of the companies Aisling Capital holds: Prescription Drugs (11%), Biologics & Biosimilars (8%), Oncology Therapeutics (7%), Drug Discovery (4%), Infectious Disease Therapeutics (3%).
Which Aisling Capital portfolio companies are hiring?
27 companies Aisling Capital holds are hiring now, with 3,178 open roles listed on this page.
Who does Aisling Capital invest alongside?
The investors that hold the most companies together with Aisling Capital: NEA, RA Capital Management, EcoR1 Capital, Foresite Capital, Sofinnova Investments.
How this page is made
A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.
Sources: its portfolio page, read Oct 25
Aisling Capital portfolio: 118 known companies. Alion, Oct 25, 2026. https://alion.io/company/aisling-capital/portfolio
